0001209191-22-050814.txt : 20220920 0001209191-22-050814.hdr.sgml : 20220920 20220920204733 ACCESSION NUMBER: 0001209191-22-050814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220916 FILED AS OF DATE: 20220920 DATE AS OF CHANGE: 20220920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EASTHAM KARIN CENTRAL INDEX KEY: 0001231845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 221254897 MAIL ADDRESS: STREET 1: C/O BURNHAM INSTITUTE FOR MEDICAL RESEAR STREET 2: 10901 N. TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-16 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001231845 EASTHAM KARIN C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2022-09-16 4 A 0 10200 0.00 A 23233 D Stock Option 3.47 2022-09-16 4 A 0 20400 0.00 A 2030-09-15 Common Stock 20400 20400 D Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. This RSU award vests in full, one year following September 16, 2022. This stock option vests in equal monthly installments over the one-year period beginning on September 16, 2022. Mark A. Wilson, Attorney-in-Fact 2022-09-20